Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes-Reference-Cited by-同舟云学术

Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes

Published:2007-10-01 Issue:10 Volume:30 Page:2506-2507
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Becker Reinhard H.A.¹,Frick Annke D.¹,Nosek Leszek²,Heinemann Lutz²,Rave Klaus²

Affiliation:

1. sanofi-aventis, Frankfurt/Main, Germany

2. Profil Institute for Metabolic Research, Neuss, Germany

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/30/10/2506/595537/zdc01007002506.pdf

Reference7 articles.

1. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 42:1151–1167, 1999

2. Monnier L, Colette C: Contributions of fasting and postprandial glucose to hemoglobin A1C. Endocr Pract 12 (Suppl. 1):42–46, 2006

3. Hennige AM, Kellerer M, Strack V, Metzinger E, Seipke G, Haring HU: New human insulin analogs: characteristics of insulin signalling in comparison to ASP (B10) and regular insulin (Abstract). Diabetologia 42:A178, 1999

4. Bakaysa DL, Radziuk J, Havel HA, Brader ML, Li S, Dodd SW, Beals JM, Pekar AH, Brems DN: Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex. Protein Sci 5:2521–2531, 1996

5. Kang S, Brange J, Burch A, Volund A, Owens DR: Subcutaneous insulin absorption explained by insulin's physicochemical properties: evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care 14:942–948, 1991

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging Clinical Pharmacology Data to Assess Biosimilarity and Interchangeability of Insulin Products;Clinical Pharmacology & Therapeutics;2022-09-19

2. Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus;Clinical Pharmacokinetics;2021-11-13

3. Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences;Diabetes mellitus;2020-06-26

4. Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences;Clinical Pharmacokinetics;2019-10-30

5. Concentrated insulins: History and critical reappraisal;Journal of Diabetes;2018-11-13